Literature DB >> 16918310

Role of ABC transporters in the chemoresistance of human gliomas.

Xavier Declèves1, Alexandra Amiel, Jean-Yves Delattre, Jean-Michel Scherrmann.   

Abstract

Malignant gliomas are frequently chemoresistant and this resistance seems to depend on at least two mechanisms. First, the poor penetration of many anticancer drugs across the blood-brain barrier (BBB), the blood-cerebrospinal fluid barrier (BCSFB) and blood-tumor barrier (BTB), due to their interaction with several ATP-binding cassette (ABC) drug efflux transporters that are overexpressed by the endothelial or epithelial cells of these barriers. Second, resistance may involve the tumor cells themselves. Although ABC drug efflux transporters in tumor cells confer multidrug resistance (MDR) on several other solid tumors, their role in gliomas is unclear. This review focuses on astrocytes and summarizes the current state of knowledge about the expression, distribution and function of ABC transporters in normal and tumor astroglial cells. The recognition of anticancer drugs by ABC transporters in astroglial cells and their participation in the multidrug resistance phenotype of human gliomas is discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16918310     DOI: 10.2174/156800906777723930

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  22 in total

Review 1.  Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors.

Authors:  Hemant Sarin
Journal:  Ther Deliv       Date:  2010-08

2.  ABC Transporter Inhibition Plus Dexamethasone Enhances the Efficacy of Convection Enhanced Delivery in H3.3K27M Mutant Diffuse Intrinsic Pontine Glioma.

Authors:  Vadim Tsvankin; Rintaro Hashizume; Hiroaki Katagi; James E Herndon; Christopher Lascola; Talaignair N Venkatraman; Daniel Picard; Brainard Burrus; Oren J Becher; Eric M Thompson
Journal:  Neurosurgery       Date:  2020-05-01       Impact factor: 4.654

Review 3.  Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.

Authors:  Sonu Bhaskar; Furong Tian; Tobias Stoeger; Wolfgang Kreyling; Jesús M de la Fuente; Valeria Grazú; Paul Borm; Giovani Estrada; Vasilis Ntziachristos; Daniel Razansky
Journal:  Part Fibre Toxicol       Date:  2010-03-03       Impact factor: 9.400

4.  New pyrazolo-[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells.

Authors:  Alessandra Rossi; Silvia Schenone; Adriano Angelucci; Martina Cozzi; Valentina Caracciolo; Francesca Pentimalli; Andrew Puca; Biagio Pucci; Raffaele La Montagna; Mauro Bologna; Maurizio Botta; Antonio Giordano
Journal:  FASEB J       Date:  2010-03-30       Impact factor: 5.191

5.  The association of statins plus LDL receptor-targeted liposome-encapsulated doxorubicin increases in vitro drug delivery across blood-brain barrier cells.

Authors:  Ml Pinzón-Daza; R Garzón; Po Couraud; Ia Romero; B Weksler; D Ghigo; A Bosia; C Riganti
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

6.  Combined use of anticancer drugs and an inhibitor of multiple drug resistance-associated protein-1 increases sensitivity and decreases survival of glioblastoma multiforme cells in vitro.

Authors:  Lilia Peigñan; Wallys Garrido; Rodrigo Segura; Rómulo Melo; David Rojas; Juan Guillermo Cárcamo; Rody San Martín; Claudia Quezada
Journal:  Neurochem Res       Date:  2011-05-05       Impact factor: 3.996

Review 7.  Extracellular vesicles shed by glioma cells: pathogenic role and clinical value.

Authors:  Dimitry A Chistiakov; Vladimir P Chekhonin
Journal:  Tumour Biol       Date:  2014-06-27

Review 8.  Multi-functional nanocarriers to overcome tumor drug resistance.

Authors:  Lara S Jabr-Milane; Lilian E van Vlerken; Sunita Yadav; Mansoor M Amiji
Journal:  Cancer Treat Rev       Date:  2008-06-05       Impact factor: 12.111

9.  Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transporters.

Authors:  V Martin; J Xu; S K Pabbisetty; M M Alonso; D Liu; O-H Lee; J Gumin; K P Bhat; H Colman; F F Lang; J Fueyo; C Gomez-Manzano
Journal:  Oncogene       Date:  2009-05-04       Impact factor: 9.867

10.  TGF-β mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells.

Authors:  Naoki Shinojima; Anwar Hossain; Tatsuya Takezaki; Juan Fueyo; Joy Gumin; Feng Gao; Felix Nwajei; Frank C Marini; Michael Andreeff; Jun-Ichi Kuratsu; Frederick F Lang
Journal:  Cancer Res       Date:  2013-01-30       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.